GB0710538D0 - Vaccine - Google Patents
VaccineInfo
- Publication number
- GB0710538D0 GB0710538D0 GB0710538A GB0710538A GB0710538D0 GB 0710538 D0 GB0710538 D0 GB 0710538D0 GB 0710538 A GB0710538 A GB 0710538A GB 0710538 A GB0710538 A GB 0710538A GB 0710538 D0 GB0710538 D0 GB 0710538D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- vaccine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 229960005486 vaccine Drugs 0.000 title 1
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0710538A GB0710538D0 (en) | 2007-06-01 | 2007-06-01 | Vaccine |
| PCT/EP2008/056719 WO2008145745A1 (fr) | 2007-06-01 | 2008-05-30 | Vaccin contre le papillomavirus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0710538A GB0710538D0 (en) | 2007-06-01 | 2007-06-01 | Vaccine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB0710538D0 true GB0710538D0 (en) | 2007-07-11 |
Family
ID=38289723
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB0710538A Ceased GB0710538D0 (en) | 2007-06-01 | 2007-06-01 | Vaccine |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB0710538D0 (fr) |
| WO (1) | WO2008145745A1 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018060288A1 (fr) * | 2016-09-29 | 2018-04-05 | Glaxosmithkline Biologicals S.A. | Compositions et méthodes de traitement d'une infection par hpv persistante |
| EP3461497A1 (fr) | 2017-09-27 | 2019-04-03 | GlaxoSmithKline Biologicals S.A. | Antigènes viraux |
| AU2019231654B2 (en) * | 2018-03-06 | 2025-12-11 | Precigen, Inc. | Human papillomavirus vaccines and uses of the same |
| AU2019231652B2 (en) | 2018-03-06 | 2025-05-22 | Precigen, Inc. | Hepatitis B vaccines and uses of the same |
| CN113528544B (zh) * | 2021-06-02 | 2022-07-08 | 郑州大学 | 编码可溶性hpv23 l1蛋白的基因及其重组质粒的构建与应用 |
| CN119529070B (zh) * | 2025-01-22 | 2025-05-09 | 成都迈科康生物科技有限公司 | 一种抗hpv16和/或hpv18型e2蛋白的抗体及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9105383D0 (en) * | 1991-03-14 | 1991-05-01 | Immunology Ltd | An immunotherapeutic for cervical cancer |
| GB0027088D0 (en) * | 2000-11-06 | 2000-12-20 | Glaxo Group Ltd | DNA expression vectors |
| PT1301614E (pt) * | 2000-07-21 | 2007-02-28 | Group Limited Glaxo | Sequências de codão optimizado do vírus do papiloma |
| GB0222953D0 (en) * | 2002-10-03 | 2002-11-13 | Glaxo Group Ltd | Novel Compounds |
-
2007
- 2007-06-01 GB GB0710538A patent/GB0710538D0/en not_active Ceased
-
2008
- 2008-05-30 WO PCT/EP2008/056719 patent/WO2008145745A1/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008145745A1 (fr) | 2008-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL199663A0 (en) | Vaccine | |
| IL201782A0 (en) | Vaccine | |
| GB0717911D0 (en) | Vaccine | |
| IL211233A0 (en) | Vaccine | |
| GB0711858D0 (en) | Vaccine | |
| IL206307A0 (en) | Vaccine | |
| IL208651A0 (en) | Vaccine | |
| AP2010005166A0 (en) | Vaccines | |
| GB0822001D0 (en) | Vaccine | |
| GB0810710D0 (en) | Vaccine | |
| IL208652A0 (en) | Vaccine | |
| GB0816284D0 (en) | Vaccine | |
| GB0816447D0 (en) | Vaccine | |
| GB0700135D0 (en) | Vaccine | |
| GB0710538D0 (en) | Vaccine | |
| ZA201003851B (en) | Vaccine | |
| GB0709373D0 (en) | BCG-based anti-atheroma vaccine | |
| GB0712420D0 (en) | Vaccine | |
| GB0708522D0 (en) | Vaccine | |
| GB0725107D0 (en) | Vaccine | |
| GB0724651D0 (en) | Vaccine | |
| GB0721928D0 (en) | Vaccine | |
| GB0713188D0 (en) | Vaccine | |
| GB0712658D0 (en) | Vaccine | |
| GB0700760D0 (en) | Vaccine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |